Compare FRMM & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRMM | BTMD |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.9M | 64.4M |
| IPO Year | 2017 | 2021 |
| Metric | FRMM | BTMD |
|---|---|---|
| Price | $1.93 | $1.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $5.00 | $2.25 |
| AVG Volume (30 Days) | 314.8K | ★ 356.0K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $2.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.00 | $1.27 |
| 52 Week High | $3.17 | $4.75 |
| Indicator | FRMM | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 19.52 | 48.83 |
| Support Level | N/A | $1.35 |
| Resistance Level | $3.14 | $1.69 |
| Average True Range (ATR) | 0.26 | 0.15 |
| MACD | -0.10 | 0.04 |
| Stochastic Oscillator | 3.12 | 63.67 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.